Angiographic characteristics of femoropopliteal in-stent restenosis: Association with long-term outcomes after endovascular intervention

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 7, 2013, Pages 1168-1174

  Armstrong, Ehrin J ^a   Singh, Satinder ^a   Singh, Gagan D ^a   Yeo, Khung Keong ^a   Ludder, Shaan ^a   Westin, Gregory ^a   Anderson, David ^a   Dawson, David L ^b   Pevec, William C ^b   Laird, John R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

in stent restenosis; peripheral arterial disease; superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; AMPUTATION; ANGIOCARDIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; ATHERECTOMY; BARE METAL STENT; CHRONIC KIDNEY DISEASE; CLAUDICATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; CYTOREDUCTIVE SURGERY; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; ENDOVASCULAR SURGERY; FEMALE; FEMOROPOPLITEAL BYPASS; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PREVALENCE; SUPERFICIAL FEMORAL ARTERY;

IN-STENT RESTENOSIS; PERIPHERAL ARTERIAL DISEASE; SUPERFICIAL FEMORAL ARTERY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; BLOOD FLOW VELOCITY; CALIFORNIA; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; RECURRENCE; REGIONAL BLOOD FLOW; REGISTRIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 84888130031     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24983     Document Type: Article

References (21)

1. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-315.
2. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012; 19: 1-9.
3. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-1888.
4. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010; 3: 267-276.
5. Dick P, Sabeti S, Mlekusch W, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: Initial experience. Radiology 2008; 248: 297-302.
6. Zeller T, Rastan A, Sixt S, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006; 48: 1573-1578.
7. Laird JR, Jr,., Yeo KK, Rocha-Singh K, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: Twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012; 80: 852-859.
8. Yeo KK, Malik U, Laird JR,. Outcomes following treatment of femoropopliteal in-stent restenosis: A single center experience. Catheter Cardiovasc Interv 2011; 78: 604-608.
9. Stabile E, Virga V, Salemme L, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012; 60: 1739-1742.
10. Dake MD, Scheinert D, Tepe G, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: Twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011; 18: 613-623.
11. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
12. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012; 59: 16-23.
13. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997; 26: 517-538.
14. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB,. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol 2009; 103: 923-929.
15. Fischer M, Schwabe C, Schulte KL,. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006; 13: 281-290.
16. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D,. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007; 45: 10-16; discussion 16.
17. Saxon RR, Coffman JM, Gooding JM, Ponec DJ,. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007; 18: 1341-1349; quiz 1350.
18. Micari A, Cioppa A, Vadala G, et al. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry. JACC Cardiovasc Interv 2012; 5: 331-338.
19. Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008; 358: 689-699.
20. Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries. Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial. Circulation 2008; 118: 1358-1365.
21. Dake MD, Ansel GM, Jaff MR, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: Twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv 2011; 4: 495-504.